RenovoRx, Inc.
RNXT
$0.972
-$0.018-1.82%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 43.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 43.00K | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 43.00K | -- | -- | -- | -- |
| SG&A Expenses | 1.10M | 1.18M | 1.49M | 1.22M | 1.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.68M | 2.83M | 3.03M | 2.48M | 1.78M |
| Operating Income | -2.63M | -2.83M | -3.03M | -2.48M | -1.78M |
| Income Before Tax | -2.88M | -2.47M | -2.39M | -1.08M | -3.23M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.88M | -2.47M | -2.39M | -1.08M | -3.23M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.88M | -2.47M | -2.39M | -1.08M | -3.23M |
| EBIT | -2.63M | -2.83M | -3.03M | -2.48M | -1.78M |
| EBITDA | -- | -- | -- | -- | -1.78M |
| EPS Basic | -0.11 | -0.10 | -0.10 | -0.07 | -0.30 |
| Normalized Basic EPS | -0.07 | -0.06 | -0.06 | -0.05 | -0.19 |
| EPS Diluted | -0.11 | -0.10 | -0.10 | -0.07 | -0.30 |
| Normalized Diluted EPS | -0.07 | -0.06 | -0.06 | -0.05 | -0.19 |
| Average Basic Shares Outstanding | 25.11M | 24.94M | 24.05M | 14.95M | 10.70M |
| Average Diluted Shares Outstanding | 25.11M | 24.94M | 24.05M | 14.95M | 10.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |